Synopsys (SNPS) Research & Development (2009 - 2026)

Synopsys (SNPS) has 18 years of Research & Development data on file, last reported at $396.4 million in Q1 2026.

• Quarterly Research & Development rose 89.47% year-over-year to $396.4 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $2.7 billion (up 81.56% YoY) and the FY2025 annual result came in at $2.5 billion, up 19.06% from the prior year.
• Research & Development slipped to $396.4 million in Q1 2026, from $1.8 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.8 billion in Q4 2025 to a low of $180.7 million in Q2 2023.
• A 5-year average of $424.6 million and a median of $215.0 million in 2025 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development soared 369.12% — and 2023, when it tumbled 81.64%.
• Tracing SNPS's Research & Development over 5 years: stood at $1.0 billion in 2022, then slumped by 81.64% to $187.0 million in 2023, then jumped by 196.77% to $554.8 million in 2024, then surged by 223.64% to $1.8 billion in 2025, then plunged by 77.93% to $396.4 million in 2026.
• The last three Research & Development figures came in at $396.4 million (Q1 2026), $1.8 billion (Q4 2025), and $259.5 million (Q3 2025), per Business Quant data.